|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
|
|---|---|---|
| Revenues | ||
| Cost of revenues | ||
| Gross profit | ||
| Operating expenses: | ||
| Selling and marketing expenses | ||
| General and administrative expenses | ||
| Research and development expenses | ||
| Total operating expenses | ||
| Operating income (loss) | ||
| Other (expenses) income: | ||
| Interest expenses, net | ||
| Government subsidies | ||
| Other income (expenses), net | ||
| Loss from sale of equipment | ||
| Loss from sale of accounts receivable | ||
| Total other expenses, net | ||
| Income (loss) before income tax | ||
| Income tax (expenses) benefit | ||
| Net income (loss) | ||
| Foreign currency translation adjustments | ||
| Total comprehensive (loss) income | ||
| Total comprehensive income (loss) | ||
| Net income (loss) per ordinary share: | ||
| Basic | ||
| Diluted | ||
| Weighted average number of shares outstanding used in calculating net income (loss) per ordinary share: | ||
| Basic | ||
| Diluted |
Loading...
